Oncocyte Corp [OCX] has reported fiscal Q1 profit of $3 million.
On a per-share basis, the CA based company said its diluted earnings are $0.02.
The In Vitro & In Vivo Diagnostic Substances firm posted revenue of $0.30 million in this period.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.